Flagship Ventures Fund IV General Partner LLC

Insider Reports History

Location
Cambridge, MA
Signature
Flagship Ventures Fund IV General Partner LLC, By: /s/ Noubar B. Afeyan, Ph.D., Name: Noubar B. Afeyan, Ph.D., Title: Manager
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Flagship Ventures Fund IV General Partner LLC:

Company Role Class Num Shares Value Price $ Report Date Ownership
Axcella Health Inc. 10%+ Owner Common Stock 14,101,638 $8,178,950 $0.5800 13 Oct 2022 By Flagship Ventures Fund IV, L.P.
Axcella Health Inc. 10%+ Owner Common Stock 6,299,611 $3,653,774 $0.5800 13 Oct 2022 By Flagship Ventures Opportunities I, L.P.
Axcella Health Inc. 10%+ Owner Common Stock 3,048,780 $1,768,292 $0.5800 13 Oct 2022 By FPA, L.P.
Evelo Biosciences, Inc. 10%+ Owner Common Stock 3,931,685 $1,297,456 $0.3300 11 Jul 2023 By Flagship Pioneering Fund VII, L.P.
Axcella Health Inc. 10%+ Owner Common Stock 2,035,830 $1,180,781 $0.5800 13 Oct 2022 By Flagship VentureLabs IV, LLC
Axcella Health Inc. 10%+ Owner Common Stock 2,004,657 $1,162,701 $0.5800 13 Oct 2022 By Flagship Ventures Fund IV-Rx, L.P.
Axcella Health Inc. 10%+ Owner Common Stock 1,761,029 $1,021,397 $0.5800 13 Oct 2022 By Flagship Ventures Fund 2007, L.P.
Evelo Biosciences, Inc. 10%+ Owner Common Stock 1,493,241 $492,770 $0.3300 11 Jul 2023 By Nutritional Health LTP Fund, L.P.
Evelo Biosciences, Inc. 10%+ Owner Common Stock 1,461,795 $482,392 $0.3300 11 Jul 2023 By Flagship Ventures Fund IV, L.P.
Evelo Biosciences, Inc. 10%+ Owner Common Stock 274,766 $90,673 $0.3300 11 Jul 2023 By Flagship Ventures Opportunities Fund I, L.P.
Evelo Biosciences, Inc. 10%+ Owner Common Stock 210,064 $69,321 $0.3300 11 Jul 2023 By Flagship Ventures Fund V, L.P.
Evelo Biosciences, Inc. 10%+ Owner Common Stock 179,909 $59,370 $0.3300 11 Jul 2023 By Nutritional Health Disruptive Innovation Fund, L.P.
Evelo Biosciences, Inc. 10%+ Owner Common Stock 132,282 $43,653 $0.3300 11 Jul 2023 By Flagship VentureLabs V LLC
Evelo Biosciences, Inc. 10%+ Owner Common Stock 94,371 $31,142 $0.3300 11 Jul 2023 By Flagship Ventures Fund IV-Rx, L.P.
Evelo Biosciences, Inc. 10%+ Owner Common Stock 80,494 $26,563 $0.3300 11 Jul 2023 By Flagship V VentureLabs Rx Fund, L.P.
Evelo Biosciences, Inc. 10%+ Owner Common Stock 39,798 $13,133 $0.3300 11 Jul 2023 By Nutritional Health Side Fund, L.P.
Evelo Biosciences, Inc. 10%+ Owner Common Stock 34,219 $11,292 $0.3300 11 Jul 2023 By Flagship VentureLabs IV LLC

Insider Reports Filed by Flagship Ventures Fund IV General Partner LLC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000095017023032871-flagship-ventures-fund-iv-general-partner-llc-2023-07-11 Evelo Biosciences, Inc. 11 Jul 2023 3 +$12,499,999 4 10%+ Owner 13 Jul 2023, 17:15
/report/000089924322033703-flagship-ventures-fund-iv-general-partner-llc-2022-10-13 Axcella Health Inc. 13 Oct 2022 5 +$17,029,366 4 10%+ Owner 17 Oct 2022, 16:42
/report/000089924322020533-flagship-ventures-fund-iv-general-partner-llc-2022-05-27 Evelo Biosciences, Inc. 27 May 2022 5 +$39,999,998 4 10%+ Owner 01 Jun 2022, 19:00
/report/000089924322011535-flagship-ventures-fund-iv-general-partner-llc-2022-03-16 Axcella Health Inc. 16 Mar 2022 3 +$12,069,999 4 10%+ Owner 18 Mar 2022, 08:30